Duquesne Family Office LLC Portfolio: Duquesne Family Office LLC 13F Q1 2026

Institutional Investor  ·  Duquesne Family Office LLC

Duquesne Family Office LLC Portfolio

Duquesne Family Office LLC · 13F Holdings · Duquesne Family Office LLC 13F Portfolio

Duquesne Family Office LLC manages Duquesne Family Office LLC, an institutional investment manager registered with the SEC (CIK: 1536411). Portfolio data sourced from Form 13F filings.

Portfolio Value
$3.38B
Q1 2026 13F
Holdings
68
Disclosed positions
Avg Annual Return
N/A
Long-term track record
Q1 2026 · SEC 13F PORTFOLIO

Duquesne Family Office LLC × Duquesne Family Office LLC

Portfolio structure and quarterly positioning at a glance.

Reported value $3.38B Filed May 15, 2026
Largest positionsWeight · Value
01
NTRANatera Inc
18.14%$612.7M
02
EWZIshares Inc
8.71%$294.2M
03
INSMInsmed Inc
5.59%$188.7M
04
TSMTaiwan Semiconductor Manufac
4.96%$167.4M
05
RSPInvesco Exchange Traded Fd T
4.67%$157.6M
42.1%Top 5
concentration
30New
12Added
20Trimmed
ALERT INVEST 68 disclosed positions Updated 2026-07-23
Duquesne Family Office LLC (Duquesne Family Office LLC) filed the Q1 2026 13F on May 15, 2026, disclosing 68 positions (equity + options) with a reported portfolio of $3.38B (includes option notional values). Top holding: NTRA — Natera Inc at 18.14% of the portfolio. New positions this quarter: 30.
Total AUM
$3.38B
↓ 24.9% vs Q4 2025
$4.49B
$3.38B
Q4 2025
$4.49B
Q1 2026
$3.38B
Positions
68
↑ +8 vs Q4 2025
New Buys
30
Initiated this quarter
Top Position
NTRA
18.14% of portfolio
Filing Date
May 15, 2026
SEC 13F-HR
Portfolio Allocation
NTRANatera
+22%18.14%
EWZIshares
-51%8.71%
INSMInsmed
-22%5.59%
TSMTaiwan Semiconductor M
-9%4.96%
RSPInvesco Exchange Trade
-30%4.67%
YPFYpf Sociedad Anonima
+433%4.43%
TBBBBbb Foods
+16%3.26%
AAAlcoa
+9%2.93%
NAMSNewamsterdam Pharmampa
2.91%
OtherRemaining positions
44.42%
Top 10 by Weight
Position Activity
Sector Exposure vs Q4 2025
Healthcare▲7.6%36.28%
Other▼3.8%17.37%
Technology▲3.0%16.48%
Consumer Disc.▼9.0%6.84%
Materials▲2.7%6.63%
Energy▲4.2%4.73%
Industrials▼3.9%3.64%
Consumer Staples▲1.4%3.61%
Comm. Services▼1.4%3.28%
Financials▼0.8%1.16%

Executing a significant $3.38 billion portfolio realignment, Duquesne Family Office LLC’s Q1 2026 13F filing revealed 68 distinct positions. Thirty new equities entered the allocation, signaling aggressive adjustments rather than minor tweaks to existing holdings. Concentration heavily skews toward top bets: NTRA commands 18.1%, EWZ holds 8.7%, INSM 5.6%, TSM 5.0%, and RSP 4.7%.

Duquesne Family Office LLC (Duquesne Family Office LLC) — Top 10 Holdings Q1 2026

Largest disclosed positions by market value. Linked tickers have an analysis page on Alert Invest.
Allocation Snapshot
NTRA Natera Inc18.14%
EWZ Ishares Inc8.71%
INSM Insmed Inc5.59%
TSM Taiwan Semiconduct4.96%
RSP Invesco Exchange T4.67%
YPF Ypf Sociedad Anoni4.43%
TBBB Bbb Foods Inc3.26%
AA Alcoa Corp2.93%
NAMS Newamsterdam Pharm2.91%
SE Sea Ltd2.7%
#1 position: NTRA — Natera Inc (18.14%)
StockWeightActivityShares ΔValue
NTRA
Natera Inc
18.14%
Add +22%+552K$612.7M
EWZ
Ishares Inc
8.71%
Reduce −51%−7.90M$294.2M
INSM
Insmed Inc
5.59%
Reduce −22%−328K$188.7M
Taiwan Semiconductor Manufac
4.96%
Reduce −9%−48K$167.4M
RSP
Invesco Exchange Traded Fd T
4.67%
Reduce −30%−353K$157.6M
YPF
Ypf Sociedad Anonima
4.43%
Add +433%+2.63M$149.6M
TBBB
Bbb Foods Inc
3.26%
Add +16%+434K$110.0M
Alcoa Corp
2.93%
Add +9%+117K$99.1M
NAMS
Newamsterdam Pharma Company
2.91%
Hold$98.3M
Sea Ltd
2.7%
Add +17%+156K$91.1M

Duquesne Family Office LLC’s Implied Market View — Q1 2026

Three key takeaways from Duquesne Family Office LLC (Duquesne Family Office LLC)’s Q1 2026 portfolio shift.
1
Duquesne exited broad market exposure, selling RSP and trimming several top positions for new names.
2
Capital shifted within biotech and semiconductors, adding AVGO, RVMD, and ARGT.
3
New allocations increase concentration risk, betting on specific growth stories and country-level volatility.

Last Quarter Activity — Duquesne Family Office LLC (Duquesne Family Office LLC) Q1 2026

Positions added and cut vs the prior 13F filing.
Last Buys & Adds
StockActionShares ΔValueWt.
YPF
Ypf Sociedad Anonima
Add +433%+2.63M$149.6M4.43%
NTRA
Natera Inc
Add +22%+552K$612.7M18.14%
STM
Stmicroelectronics N V
Add +238%+1.84M$90.3M2.67%
Broadcom Inc
New Buy+196K new$60.6M1.8%
ARGT
Global X Fds
New Buy+387K new$36.2M1.07%
CAI
Caris Life Sciences Inc
New Buy+1.89M new$33.9M1.0%
RVMD
Revolution Medicines Inc
New Buy+316K new$30.7M0.91%
Sandisk Corp
New Buy+38K new$24.2M0.72%

QoQ change vs Dec 2025 filing.

Last Sells & Exits
StockActionShares ΔValueWt.
EWZ
Ishares Inc
Reduce −51%−7.90M$294.2M8.71%
INSM
Insmed Inc
Reduce −22%−328K$188.7M5.59%
Taiwan Semiconductor Manufac
Reduce −9%−48K$167.4M4.96%
RSP
Invesco Exchange Traded Fd T
Reduce −30%−353K$157.6M4.67%
WWD
Woodward Inc
Reduce −64%−380K$75.6M2.24%
TEVA
Teva Pharmaceutical Inds Ltd
Reduce −60%−3.50M$71.6M2.12%
AEVA
AEVA
Aeva Technologies Inc
Full ExitSold 100%$24.2M0%
GOOG
GOOGL
Alphabet Inc
Full ExitSold 100%$120.5M0%
AAL
AAL
American Airls Group Inc
Full ExitSold 100%$9.8M0%
AGX
AGX
Argan Inc
Full ExitSold 100%$9.4M0%

QoQ change vs Dec 2025 filing.

New Positions — Duquesne Family Office LLC (Duquesne Family Office LLC) Q1 2026

Duquesne Family Office LLC (Duquesne Family Office LLC) initiated 30 fresh positions this quarter.

Duquesne Family Office LLC made significant new purchases in Q1 2026, allocating $60.6 million to Broadcom Inc. This move captures exposure to semiconductor infrastructure and enterprise software. Argentina’s equity market drew $36.2 million through the Global X MSCI Argentina ETF (ARGT), signaling a bet on economic recovery. Caris Life Sciences Inc received a $33.9 million allocation, reflecting a conviction in precision medicine and cancer diagnostics.

Duquesne’s Q1 activity reveals a dual focus: high-conviction technology and specific macro bets. Revolution Medicines Inc, a new $30.7 million position, expands the firm’s biotech exposure. Adding $24.2 million to Sandisk Corp reinforces a bet on data storage and memory solutions. Humana Inc, a $23.8 million addition, demonstrates an interest in managed healthcare. The firm actively seeks growth drivers across disparate sectors, from advanced semiconductors to emerging market equities and targeted medical innovation.

AVGO — $60.6M
Broadcom Inc
AVGO entered Duquesne Family Office LLC’s portfolio at $60.6M, representing 1.80% of AUM.
 See AVGO analyst sentiment
ARGT — $36.2M
Global X Fds
ARGT entered Duquesne Family Office LLC’s portfolio at $36.2M, representing 1.07% of AUM.
CAI — $33.9M
Caris Life Sciences Inc
CAI entered Duquesne Family Office LLC’s portfolio at $33.9M, representing 1.00% of AUM.
RVMD — $30.7M
Revolution Medicines Inc
RVMD entered Duquesne Family Office LLC’s portfolio at $30.7M, representing 0.91% of AUM.
StockActionValue
Broadcom Inc
New Buy$60.6M
 See AVGO analyst sentiment
ARGT
Global X Fds
New Buy$36.2M
CAI
Caris Life Sciences Inc
New Buy$33.9M
RVMD
Revolution Medicines Inc
New Buy$30.7M
Sandisk Corp
New Buy$24.2M
 See SNDK analyst sentiment
HUM
Humana Inc
New Buy$23.8M
TWLO
Twilio Inc
New Buy$22.9M
Jabil Inc
New Buy$21.8M
 See JBL analyst sentiment
GSG
Ishares S&P Gsci Commodity-
New Buy$20.7M
Linde Plc
New Buy$20.4M
 See LIN analyst sentiment
STX
Seagate Technology Hldngs Pl
New Buy$19.9M
NUVB
Nuvation Bio Inc
New Buy$19.5M
Intel Corp
New Buy$18.2M
 See INTC analyst sentiment
BLTE
Belite Bio Inc Sponsored
New Buy$16.9M
Arm Holdings Plc
New Buy$16.1M
 See ARM analyst sentiment
OLMA
Olema Pharmaceuticals Inc
New Buy$14.7M
Q
Qnity Electronics Inc
New Buy$14.5M
XENE
Xenon Pharmaceuticals Inc
New Buy$13.9M
JBS
Jbs N.V.
New Buy$11.8M
NET
Cloudflare Inc
New Buy$10.8M
LYB
Lyondellbasell Industries Nv
New Buy$10.6M
VIST
Vista Energy S.A.B. De C.V.
New Buy$10.2M
TWST
Twist Bioscience Corp
New Buy$9.8M
COHR
Coherent Corp
New Buy$9.6M
CLS
Celestica Inc
New Buy$9.4M
DBVT
Dbv Technologies S A Sponsored
New Buy$8.0M
Micron Technology Inc
New Buy$7.9M
 See MU analyst sentiment
LITE
Lumentum Hldgs Inc
New Buy$4.9M
SOLS
Solstice Advanced Matls Inc
New Buy$4.8M
WLK
Westlake Corporation
New Buy$2.5M

Increased Positions — Duquesne Family Office LLC (Duquesne Family Office LLC)

Where Duquesne Family Office LLC (Duquesne Family Office LLC) added to existing stakes in Q1 2026.

Duquesne Family Office added aggressively to existing positions during Q1 2026, confirming belief in specific names. Netzsch AG (NTRA) received a 22% bump, raising the firm’s stake to $612.7 million. Argentine oil producer YPF SA (YPF) saw the most dramatic increase; Duquesne expanded its holding by 433%, pushing the position to $149.6 million. This sharp acceleration in YPF demonstrates a renewed emphasis on the company.

Additional existing holdings also grew. Trinity Biotech PLC (TBBB) saw a 16% increase, with Duquesne’s position reaching $110.0 million. Alcoa Corp. (AA) grew by 9%, making the stake $99.1 million. Sea Ltd. (SE) also expanded, rising 17% to $91.1 million. These additions across multiple companies show Duquesne reinforcing its bets.

StockActionValue
NTRA
Natera Inc
Add +22%$612.7M
YPF
Ypf Sociedad Anonima
Add +433%$149.6M
TBBB
Bbb Foods Inc
Add +16%$110.0M
Alcoa Corp
Add +9%$99.1M
Sea Ltd
Add +17%$91.1M
STM
Stmicroelectronics N V
Add +238%$90.3M
ROKU
Roku Inc
Add +29%$71.0M
OPCH
Option Care Health Inc
Add +7%$50.3M
SCCO
Southern Copper Corp
Add +1%$21.0M
CLF
Cleveland-Cliffs Inc New
Add +33%$19.5M
U
Unity Software Inc
Add +80%$16.2M
ADMA
Adma Biologics Inc
Add +513%$13.9M

Stocks Sold or Reduced — Duquesne Family Office LLC (Duquesne Family Office LLC) Q1 2026

Complete exits and major trims by Duquesne Family Office LLC (Duquesne Family Office LLC) this quarter.

Duquesne Family Office LLC significantly trimmed its holdings during Q1 2026, shedding exposure across several key positions. The institutional investment manager, registered with the SEC, cut its Ishares Inc (EWZ) stake by a sharp 51%. Woodward Inc (WWD) saw an even steeper reduction, down 64%, while Teva Pharmaceutical Inds Ltd (TEVA) experienced a 60% cut. These moves suggest a re-evaluation of specific sectors or geographies.

Further adjustments reshaped Duquesne’s portfolio composition. The firm reduced its position in Invesco Exchange Traded Fd T (RSP) by 30%, decreasing its broad market exposure. Insmed Inc (INSM) saw a 22% reduction. Taiwan Semiconductor Manufac (TSM) received the smallest cut among the reported reductions, down 9%. These actions reveal a tactical shift in allocation, selectively de-risking positions rather than initiating wholesale exits.

StockActionΔ ValueShares Δ
EWZ
Ishares Inc
Reduce −51%$294.2M7.90M
INSM
Insmed Inc
Reduce −22%$188.7M328K
Taiwan Semiconductor Manufac
Reduce −9%$167.4M48K
RSP
Invesco Exchange Traded Fd T
Reduce −30%$157.6M353K
WWD
Woodward Inc
Reduce −64%$75.6M380K
TEVA
Teva Pharmaceutical Inds Ltd
Reduce −60%$71.6M3.50M
Amazon Com Inc
Reduce −85%$51.2M1.43M
CPNG
Coupang Inc
Reduce −61%$50.4M4.11M
CRH
Crh Plc
Reduce −21%$39.7M97K
FIGR
Figure Technology Solutio
Reduce −25%$39.1M389K
QSR
Restaurant Brands Intl Inc
Reduce −62%$33.6M755K
LSCC
Lattice Semiconductor Corp
Reduce −65%$30.0M603K
UAL
United Airls Hldgs Inc
Reduce −25%$24.2M86K
WAB
Wabtec
Reduce −68%$23.7M205K
IWM
Ishares Tr
Reduce −65%$19.6M147K
BE
Bloom Energy Corp
Reduce −82%$18.5M604K
DAKT
Daktronics Inc
Reduce −34%$11.0M290K
STUB
Stubhub Hldgs Inc
Reduce −41%$8.5M939K
PCT
Purecycle Technologies Inc
Reduce −67%$5.0M1.92M
MELI
Mercadolibre Inc
Reduce −94%$4.8M44K

Why Duquesne Family Office LLC’s (Duquesne Family Office LLC) Moves Matter

Duquesne Family Office LLC repositioned its holdings during Q1 2026, initiating 30 new investments. Natera (NTRA) became the largest position, accounting for 18.1% of the portfolio, a $612.7 million stake. The iShares MSCI Brazil ETF (EWZ) followed, taking 8.7% at $294.2 million. Insmed (INSM) comprised the third largest holding, 5.6% valued at $188.7 million. This investment pattern — a strong tilt toward specialized biotechnology firms and significant exposure to Brazilian equities — indicates a precise macro view: conviction in specific growth sectors and targeted international markets, rather than a generalized market bet.

Retail investors scrutinizing these Duquesne Family Office LLC filings gain insight into institutional strategy, not immediate buy signals. Managers submit Form 13F disclosures 45 days after quarter-end, meaning Q1 2026 data reflects decisions made up to March 31. This time lag makes replicating positions impractical for short-term gains. Duquesne Family Office LLC, an institutional investment manager, operates with extensive research capabilities; individual investors should use 13F data to understand professional investment processes and potential areas of interest, rather than as a trading guide.

About Duquesne Family Office LLC — Duquesne Family Office LLC

Duquesne Family Office LLC manages Duquesne Family Office LLC, an institutional investment manager registered with the SEC (CIK: 1536411). Portfolio data sourced from Form 13F filings.

  • Manages Duquesne Family Office LLC — SEC-registered institutional investment manager
  • CIK: 1536411 — Required to disclose equity holdings quarterly via Form 13F

Duquesne Family Office LLC (Duquesne Family Office LLC) — Complete Q1 2026 13F Holdings

All 68 positions disclosed — sorted by portfolio weight.
StockWeightActivityShares ΔValue
NTRA
Natera Inc
18.14%
Add +22%+552K$612.7M
EWZ
Ishares Inc
8.71%
Reduce −51%−7.90M$294.2M
INSM
Insmed Inc
5.59%
Reduce −22%−328K$188.7M
Taiwan Semiconductor Manufac
4.96%
Reduce −9%−48K$167.4M
RSP
Invesco Exchange Traded Fd T
4.67%
Reduce −30%−353K$157.6M
YPF
Ypf Sociedad Anonima
4.43%
Add +433%+2.63M$149.6M
TBBB
Bbb Foods Inc
3.26%
Add +16%+434K$110.0M
Alcoa Corp
2.93%
Add +9%+117K$99.1M
NAMS
Newamsterdam Pharma Company
2.91%
Hold$98.3M
Sea Ltd
2.7%
Add +17%+156K$91.1M
STM
Stmicroelectronics N V
2.67%
Add +238%+1.84M$90.3M
WWD
Woodward Inc
2.24%
Reduce −64%−380K$75.6M
TEVA
Teva Pharmaceutical Inds Ltd
2.12%
Reduce −60%−3.50M$71.6M
ROKU
Roku Inc
2.1%
Add +29%+167K$71.0M
Broadcom Inc
1.8%
New Buy+196K new$60.6M
SPY
State Str Spdr S&P 500 Etf T
1.73%
Hold$58.5M
Amazon Com Inc
1.52%
Reduce −85%−1.43M$51.2M
CPNG
Coupang Inc
1.49%
Reduce −61%−4.11M$50.4M
OPCH
Option Care Health Inc
1.49%
Add +7%+123K$50.3M
CRH
Crh Plc
1.18%
Reduce −21%−97K$39.7M
FIGR
Figure Technology Solutio
1.16%
Reduce −25%−389K$39.1M
ARGT
Global X Fds
1.07%
New Buy+387K new$36.2M
CAI
Caris Life Sciences Inc
1.0%
New Buy+1.89M new$33.9M
QSR
Restaurant Brands Intl Inc
0.99%
Reduce −62%−755K$33.6M
RVMD
Revolution Medicines Inc
0.91%
New Buy+316K new$30.7M
LSCC
Lattice Semiconductor Corp
0.89%
Reduce −65%−603K$30.0M
Sandisk Corp
0.72%
New Buy+38K new$24.2M
UAL
United Airls Hldgs Inc
0.72%
Reduce −25%−86K$24.2M
HUM
Humana Inc
0.71%
New Buy+138K new$23.8M
WAB
Wabtec
0.7%
Reduce −68%−205K$23.7M
TWLO
Twilio Inc
0.68%
New Buy+182K new$22.9M
Jabil Inc
0.65%
New Buy+82K new$21.8M
SCCO
Southern Copper Corp
0.62%
Add +1%+1K$21.0M
GSG
Ishares S&P Gsci Commodity-
0.61%
New Buy+643K new$20.7M
Linde Plc
0.6%
New Buy+41K new$20.4M
STX
Seagate Technology Hldngs Pl
0.59%
New Buy+51K new$19.9M
IWM
Ishares Tr
0.58%
Reduce −65%−147K$19.6M
CLF
Cleveland-Cliffs Inc New
0.58%
Add +33%+568K$19.5M
NUVB
Nuvation Bio Inc
0.58%
New Buy+4.54M new$19.5M
BE
Bloom Energy Corp
0.55%
Reduce −82%−604K$18.5M
Intel Corp
0.54%
New Buy+411K new$18.2M
BLTE
Belite Bio Inc Sponsored
0.5%
New Buy+106K new$16.9M
PTGX
Protagonist Therapeutics Inc
0.5%
Hold$16.8M
U
Unity Software Inc
0.48%
Add +80%+329K$16.2M
Arm Holdings Plc
0.48%
New Buy+107K new$16.1M
OLMA
Olema Pharmaceuticals Inc
0.44%
New Buy+987K new$14.7M
Q
Qnity Electronics Inc
0.43%
New Buy+126K new$14.5M
ADMA
Adma Biologics Inc
0.41%
Add +513%+1.29M$13.9M
XENE
Xenon Pharmaceuticals Inc
0.41%
New Buy+239K new$13.9M
JBS
Jbs N.V.
0.35%
New Buy+656K new$11.8M
DAKT
Daktronics Inc
0.33%
Reduce −34%−290K$11.0M
NET
Cloudflare Inc
0.32%
New Buy+53K new$10.8M
LYB
Lyondellbasell Industries Nv
0.31%
New Buy+131K new$10.6M
VIST
Vista Energy S.A.B. De C.V.
0.3%
New Buy+135K new$10.2M
TWST
Twist Bioscience Corp
0.29%
New Buy+206K new$9.8M
COHR
Coherent Corp
0.29%
New Buy+40K new$9.6M
CLS
Celestica Inc
0.28%
New Buy+33K new$9.4M
STUB
Stubhub Hldgs Inc
0.25%
Reduce −41%−939K$8.5M
DBVT
Dbv Technologies S A Sponsored
0.24%
New Buy+383K new$8.0M
Micron Technology Inc
0.23%
New Buy+23K new$7.9M
SATS
Echostar Corp
0.21%
Hold$7.1M
ALM
Almonty Inds Inc
0.2%
Hold$6.8M
PCT
Purecycle Technologies Inc
0.15%
Reduce −67%−1.92M$5.0M
LITE
Lumentum Hldgs Inc
0.14%
New Buy+7K new$4.9M
MELI
Mercadolibre Inc
0.14%
Reduce −94%−44K$4.8M
SOLS
Solstice Advanced Matls Inc
0.14%
New Buy+63K new$4.8M
WLK
Westlake Corporation
0.07%
New Buy+21K new$2.5M
WVE
Wave Life Sciences Ltd
0.04%
Hold$1.3M

For informational purposes only. Not investment advice. Data: sec-api.io & SEC EDGAR 13F-HR filings. Duquesne Family Office LLC (Duquesne Family Office LLC) 13F filings are filed 45 days after quarter end — positions may have changed. Last updated: 2026-07-23.